Plasminogen activator inhibitor-1 (PAI-1) in children and adolescents With Type 1 Diabetes Mellitus: relation to diabetic micro-vascular complications and carotid intima media thickness
- 1 May 2014
- journal article
- Published by Elsevier BV in Journal of Diabetes and its Complications
- Vol. 28 (3), 340-347
- https://doi.org/10.1016/j.jdiacomp.2014.01.011
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Metabolic Factors, Adipose Tissue, and Plasminogen Activator Inhibitor-1 Levels in Type 2 DiabetesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- REVIEW: Plasminogen Activator Inhibitor‐1 (PAI‐1): A Key Factor Linking Fibrinolysis and Age‐Related Subclinical and Clinical ConditionsCardiovascular Therapeutics, 2010
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2010
- Growth Curves for Cardio-Metabolic Risk Factors in Children and AdolescentsThe Journal of Pediatrics, 2009
- A predisposição genética para o desenvolvimento da microangiopatia no DM1Archives of Endocrinology and Metabolism, 2008
- Arterial wall thickening and stiffening in children and adolescents with type 1 diabetesDiabetes Research and Clinical Practice, 2006
- Carotid Intima-Media Thickness: An Index for Subclinical Atherosclerosis in Type 1 DiabetesJournal of Tropical Pediatrics, 2005
- Augmentation de la concentration plasmatique de la protéine C-réactive dans le diabète de l’enfant et de l’adulte jeuneLa Presse Médicale, 2005
- Relationship between plasma plasminogen activator inhibitor 1 and insulin resistanceDiabetes/Metabolism Research and Reviews, 2000
- Association of Coronary Disease With Segment-Specific Intimal-Medial Thickening of the Extracranial Carotid ArteryCirculation, 1995